Entity Common Stock, Shares Outstanding of BioCorRx Inc. from Q2 2011 to Q2 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioCorRx Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q2 2025.
  • BioCorRx Inc. Entity Common Stock, Shares Outstanding for the quarter ending 08 Aug 2025 was 23.7M shares, a 117% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BioCorRx Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 23.7M +12.8M +117% 08 Aug 2025 10-Q 14 Nov 2025
Q1 2025 16.1M +7.28M +82.6% 31 Mar 2025 10-K 31 Mar 2025
Q3 2024 12.7M +4.15M +48.3% 14 Nov 2024 10-Q 14 Nov 2024
Q2 2024 10.9M +2.37M +27.7% 12 Aug 2024 10-Q 13 Aug 2024
Q1 2024 8.82M +1.08M +13.9% 29 Mar 2024 10-K 01 Apr 2024
Q3 2023 8.6M +971K +12.7% 13 Nov 2023 10-Q 14 Nov 2023
Q2 2023 8.52M +1.44M +20.3% 11 Aug 2023 10-Q 14 Aug 2023
Q1 2023 7.74M +792K +11.4% 30 Mar 2023 10-K 31 Mar 2023
Q3 2022 7.63M +938K +14% 11 Nov 2022 10-Q 14 Nov 2022
Q2 2022 7.09M +456K +6.87% 12 Aug 2022 10-Q 15 Aug 2022
Q1 2022 6.95M +348K +5.27% 30 Mar 2022 10-K 31 Mar 2022
Q3 2021 6.69M +1.27M +23.4% 12 Nov 2021 10-Q 15 Nov 2021
Q2 2021 6.63M +1.25M +23.2% 13 Aug 2021 10-Q 13 Aug 2021
Q1 2021 6.6M +1.26M +23.6% 30 Mar 2021 10-K 31 Mar 2021
Q3 2020 5.42M +120K +2.27% 13 Nov 2020 10-Q 16 Nov 2020
Q2 2020 5.38M +2.32M +76% 13 Aug 2020 10-Q 14 Aug 2020
Q1 2020 5.34M +2.31M +76.2% 27 Mar 2020 10-K 30 Mar 2020
Q3 2019 5.3M -248M -97.9% 14 Nov 2019 10-Q 14 Nov 2019
Q2 2019 3.06M -244M -98.8% 13 Aug 2019 10-Q 14 Aug 2019
Q1 2019 3.03M -244M -98.8% 15 Apr 2019 10-K 16 Apr 2019
Q3 2018 253M +10.1M +4.13% 14 Nov 2018 10-Q 14 Nov 2018
Q2 2018 247M +4.98M +2.06% 18 May 2018 10-Q 18 May 2018
Q1 2018 247M +33.9M +15.9% 02 Apr 2018 10-K 05 Apr 2018
Q3 2017 243M +77.1M +46.4% 14 Nov 2017 10-Q 14 Nov 2017
Q2 2017 242M +76.7M +46.4% 11 Aug 2017 10-Q 11 Aug 2017
Q1 2017 213M +47.3M +28.6% 13 Apr 2017 10-K 13 Apr 2017
Q3 2016 166M 17 Aug 2016 10-Q 17 Aug 2016
Q2 2016 165M +8.66M +5.53% 23 May 2016 10-Q 23 May 2016
Q1 2016 165M +16.3M +10.9% 12 Apr 2016 10-K 14 Apr 2016
Q4 2015 159M 16 Nov 2015 10-Q 16 Nov 2015
Q2 2015 157M +14.8M +10.4% 12 Aug 2015 10-Q 12 Aug 2015
Q1 2015 149M +19.3M +14.9% 31 Mar 2015 10-K 31 Mar 2015
Q3 2014 145M +27.6M +23.4% 10 Nov 2014 10-Q 10 Nov 2014
Q2 2014 142M 13 Aug 2014 10-Q 14 Aug 2014
Q1 2014 130M +14.5M +12.5% 11 Apr 2014 10-K 14 Apr 2014
Q3 2013 118M +17.1M +17% 19 Aug 2013 10-Q 19 Aug 2013
Q1 2013 115M 15 May 2013 10-Q 15 May 2013
Q4 2012 115M 31 Dec 2012 10-K 15 Apr 2013
Q3 2012 101M +25.3M +33.6% 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 100M +25M +33.2% 30 Jun 2012 10-Q/A 24 Sep 2012
Q3 2011 75.4M 30 Sep 2011 10-Q/A 27 Feb 2012
Q2 2011 75.4M 30 Jun 2011 10-Q/A 01 Nov 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.